Cart
0
Orders
CURENEX LIPO product image

CURENEX LIPO

Compare CURENEX LIPO at TEOSQUARE: a Korean professional contouring solution with botanical extracts, 10 mL x 5 vials, and product specifications.
★0(0)
Main Composition
Fucus Vesiculosus Extract, Aesculus Hippocastanum
Country of Origin
REPUBLIC OF KOREA

Product Range


CURENEX LIPO
$ 106
10 mL
5 Vials / 1 Box
Not available here
i

Suggested Collaboration


Details about CURENEX LIPO


Product Overview

CURENEX LIPO is a professional face and body contouring solution from the Korean CURENEX brand, operated by K Derma Co., Ltd. It is supplied in a box of five 10 mL vials (50 mL total) and features extracts of Fucus vesiculosus, Cynara scolymus, Aesculus hippocastanum, and Fumaria officinalis. For professional buyers comparing contouring products, the key distinctions are its botanical-focused ingredient profile, vial presentation, and different positioning from CURENEX Glow. Its marketing description does not establish clinically proven fat reduction or regulatory authorization for injection.

Key Features

  • Four highlighted botanical extracts. The official CURENEX LIPO product description identifies brown seaweed, artichoke, horse chestnut, and fumitory extracts as its principal featured ingredients.
  • Face and body contouring positioning. K Derma markets CURENEX LIPO as a professional contouring solution for aesthetic programs involving facial and body areas; this does not establish approved medical indications.
  • Three-part formulation concept. The brand describes lipid-metabolism support, circulation support, and skin-firming support as its formulation rationale, without publishing product-specific quantitative clinical results on its product page.
  • Five-vial commercial presentation. The listed pack contains five 10 mL vials (50 mL total); confirm the supplied SKU against its carton.
  • Distinct from CURENEX Glow. LIPO emphasizes botanical contouring ingredients, whereas CURENEX Glow is presented as a PDRN- and multi-peptide-based skin-conditioning formula.

Composition & Specifications

CURENEX LIPO product and packaging specifications
Specification Details
Product Name CURENEX LIPO (Curenex Lipo Solution)
Product Category Professional aesthetic contouring solution; regulatory classification varies by market and requires verification
Brand Company K Derma Co., Ltd., Republic of Korea
Featured Extract — Brown Seaweed Fucus vesiculosus extract
Featured Extract — Artichoke Cynara scolymus leaf extract
Featured Extract — Horse Chestnut Aesculus hippocastanum extract
Featured Extract — Fumitory Fumaria officinalis flower/leaf/stem extract
Other Ingredients Listed by the US Brand Distributor Water, sodium chloride, ascorbic acid, Hieracium pilosella extract, thiamine HCl, riboflavin, pyridoxine, niacinamide, magnesium ascorbyl phosphate, magnesium gluconate, and Equisetum arvense; confirm the complete ingredient declaration against the actual supplied label
Concentrations of Botanical Extracts Not publicly verified in the reviewed official Korean brand materials
Lidocaine Content Not established as an ingredient of the standard vial; verify the product label
Volume per Vial 10 mL
Package Configuration 5 vials per box (50 mL total)
Country of Brand Origin Republic of Korea

The Korean brand website confirms the four featured extracts and pack size. Additional ingredients are described by a CURENEX US distribution website and should be checked against the batch-specific manufacturer label. No manufacturer-issued ingredient concentrations or market-specific injectable authorization were independently confirmed.

How the Formula Is Positioned

K Derma describes CURENEX LIPO through three complementary product concepts. Brown seaweed (Fucus vesiculosus) and artichoke (Cynara scolymus) extracts are associated by the brand with lipid-metabolism support. Horse chestnut (Aesculus hippocastanum) is highlighted for circulation-related positioning, while fumitory (Fumaria officinalis) is included within the skin-conditioning and firming concept.

These descriptions explain the brand's formulation rationale; they do not establish that CURENEX LIPO destroys fat cells, produces a measurable reduction in fat thickness, treats vascular conditions, or stimulates collagen production in humans. The individual botanical ingredients have different chemical constituents, and their behavior in a finished professional-use solution depends on factors such as concentration, formulation, and authorized route of use. No product-specific controlled clinical efficacy data were verified in the reviewed official materials.

Professional Product Selection Considerations

When evaluating CURENEX LIPO for a professional purchasing list, confirm that the product offered is the LIPO formulation rather than CURENEX Glow or another CURENEX solution. The listed LIPO pack contains five 10 mL vials, while the brand positions its formula around four featured botanical extracts. The exact full ingredient declaration and botanical concentrations should be checked on the supplied label.

  • Product identity and pack size. Match the CURENEX LIPO name, 10 mL vial fill, five-vial box and batch information against the commercial packaging.
  • Ingredient and lidocaine verification. Do not assume a lidocaine concentration or specific botanical amounts without the applicable product label and formulation documentation.
  • Market eligibility and authorized use. Check local classification, permitted route of use, labeling and professional-use requirements before sourcing for a destination market.
  • Storage and traceability. Verify the carton storage instructions, expiration date and lot identification, rather than relying solely on distributor descriptions.

This product-information comparison supports identification and purchasing review. It does not establish authorization for injection, efficacy for fat reduction, or availability in a particular market.

Storage & Handling

The CURENEX US distribution listing states 2–25°C storage away from direct sunlight. A definitive temperature specification on a current K Derma manufacturer-issued label or technical document was not independently verified. Follow the temperature range and expiration date printed on the actual supplied packaging; do not substitute distributor advice for official product labeling.

CURENEX LIPO is marketed for professional aesthetic use. The term “contouring solution” does not, by itself, establish approval as an injectable drug or medical device. Only appropriately qualified professionals should assess its legal classification and authorized use in the destination market. Do not use a damaged, improperly stored, or expired vial. No injection or application protocol is provided here.

Frequently Asked Questions

What is CURENEX LIPO?

CURENEX LIPO is a professional contouring solution from the Korean CURENEX brand. Its listed commercial presentation is five 10 mL vials per box, featuring four highlighted botanical extracts. Buyers should distinguish its formula and packaging from other CURENEX products.

Which botanical ingredients are highlighted in CURENEX LIPO?

The official brand identifies Fucus vesiculosus (brown seaweed), Cynara scolymus (artichoke), Aesculus hippocastanum (horse chestnut), and Fumaria officinalis (fumitory). Their exact concentrations were not confirmed in the publicly reviewed brand documentation.

How many vials are in a CURENEX LIPO box?

The official Korean CURENEX product page specifies five 10 mL vials per box, equivalent to 50 mL of solution in total.

Does CURENEX LIPO contain lidocaine?

The reviewed CURENEX US ingredient listing does not include lidocaine, but some independent reseller descriptions mention it separately. Lidocaine should not be assumed to be contained in the original vial without confirmation from its manufacturer-issued label.

How is CURENEX LIPO different from CURENEX Glow?

CURENEX LIPO is positioned around botanical extracts and facial or body contouring, while CURENEX Glow focuses on PDRN, a multi-peptide complex, hyaluronic acid, and other skin-conditioning ingredients. Their pack sizes also differ: LIPO is listed as 10 mL × 5 vials, and Glow as 5 mL × 5 vials.

Is CURENEX LIPO approved as a fat-dissolving injection?

A market-specific injectable-drug or medical-device authorization for CURENEX LIPO was not established from the reviewed sources. Professional marketing language should not be interpreted as a regulatory approval or proof of fat-reduction efficacy.

Product Information Sources

Reviews

★0(0)

Loading reviews...